A highly selective pentapeptide and ghrelin receptor agonist used as a research tool for investigating somatotropic signaling. It is studied for its ability to activate intracellular calcium-dependent pathways with minimal engagement of secondary pituitary hormones. For research use only. Not for human consumption.
Ipamorelin is a synthetic pentapeptide commonly studied as a selective growth hormone secretagogue in experimental research. It interacts with the growth hormone secretagogue receptor (GHS-R1a), also referred to as the ghrelin receptor, and is used in laboratory models to examine receptor-mediated growth hormone signaling.
In preclinical studies, Ipamorelin has been shown to activate intracellular calcium signaling through G-protein–coupled pathways associated with phospholipase C activity. Research literature describes its relatively high receptor selectivity, with limited engagement of other pituitary hormone pathways when evaluated under controlled experimental conditions. This selectivity has made Ipamorelin a useful compound for studying somatotropic signaling mechanisms, pituitary receptor pharmacology, and peptide-driven regulation of growth-related biological processes.
Because of these characteristics, Ipamorelin continues to serve as a research tool in investigations focused on growth hormone axis modulation and peptide–receptor interaction dynamics.
For research use only. Not for human consumption.
References
Svensson J, et al. Journal of Endocrinological Investigation. 1998;21(9):692–699.
Bowers CY, et al. Annals of the New York Academy of Sciences. 1998;865:244–249.
Raun K, et al. European Journal of Endocrinology. 1998;139(5):552–561.